David P Hajjar Selected Research

David P Hajjar Research Topics

Disease

16	Atherosclerosis 01/2016 - 10/2002
6	Inflammation (Inflammations) 01/2016 - 06/2004
4	Thrombosis (Thrombus) 01/2016 - 09/2003
3	Vascular Diseases (Vascular Disease) 09/2010 - 06/2004
2	Dyslipidemias (Dyslipidemia) 01/2020 - 04/2015
2	Coronary Disease (Coronary Heart Disease) 11/2004 - 06/2004
1	Necrosis 01/2020
1	Intrahepatic Cholestasis 01/2020
1	Cholestasis 01/2020
1	Ketosis 01/2019
1	Transient Ischemic Attack 01/2016
1	Hypercholesterolemia 01/2016
1	Myocardial Infarction 01/2016
1	Obesity 01/2016
1	Stroke (Strokes) 01/2016
1	Hypertriglyceridemia 04/2015
1	Carcinoma (Carcinomatosis) 04/2014
1	Hypertension (High Blood Pressure) 08/2011
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2008
1	Vascular System Injuries 01/2008
1	Persistent Infection 06/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2002

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 01/2019 - 09/2003
5	CholesterolIBA 01/2016 - 06/2002
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2010 - 07/2006
4	LigandsIBA 04/2015 - 06/2009
4	oxidized low density lipoproteinIBA 12/2012 - 10/2002
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2007
3	Liver X ReceptorsIBA 04/2015 - 12/2012
2	T0901317IBA 04/2015 - 04/2014
2	Apolipoproteins E (ApoE)IBA 04/2015 - 11/2007
2	Transcription Factors (Transcription Factor)IBA 04/2014 - 12/2012
2	Fatty Acid-Binding ProteinsIBA 09/2013 - 06/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2010 - 11/2009
2	HDL LipoproteinsIBA 02/2010 - 06/2002
2	PPAR gammaIBA 06/2009 - 05/2004
2	LDL Receptors (LDL Receptor)IBA 06/2009 - 01/2008
2	EicosanoidsIBA 01/2007 - 07/2006
2	Coenzyme A (CoA)IBA 11/2004 - 09/2003
2	pitavastatin (itavastatin)FDA Link 11/2004 - 09/2003
2	LDL Lipoproteins (beta Lipoproteins)IBA 06/2004 - 10/2002
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Rosiglitazone (Avandia)FDA Link 01/2020
1	15-deoxyprostaglandin J2IBA 01/2020
1	CarbohydratesIBA 01/2019
1	InflammasomesIBA 01/2016
1	EnzymesIBA 01/2016
1	SterolsIBA 01/2016
1	U 0126 (UO 126)IBA 04/2015
1	MAP Kinase Kinase 1IBA 04/2015
1	Interleukin-5 (Interleukin 5)IBA 12/2012
1	Immunoglobulin M (IgM)IBA 12/2012
1	AntibodiesIBA 12/2012
1	ferric chlorideIBA 08/2011
1	Protein Isoforms (Isoforms)IBA 08/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2010
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2010
1	ProstaglandinsIBA 11/2009
1	Angiotensin IIIBA 11/2009
1	Pioglitazone (Actos)FDA Link 06/2009
1	CytokinesIBA 11/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2004
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 11/2004
1	C-Reactive ProteinIBA 06/2004
1	Peroxynitrous Acid (Peroxynitrite)IBA 06/2004
1	Reactive Nitrogen SpeciesIBA 06/2004
1	Oxidoreductases (Dehydrogenase)IBA 09/2003
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2002

Therapy/Procedure

4	Therapeutics 01/2016 - 06/2004